Defining key design elements of registry-based randomised controlled trials: a scoping review
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Traditional randomised controlled trials remain the gold standard for improving clinical care but they do have their limitations, including their associated high costs, high failure rate and limited external validity. An alternative methodology is the newly defined, prospective, registry-based randomised controlled trial (RRCT), where treatment and outcome data is collected in an existing registry. This scoping review explores the current literature regarding RRCTs to help identify the key design elements of RRCTs and the characteristics of clinical registries on which they are reliant on. Methods: A scoping review methodology conducted in accordance with the Joanna Briggs Institute guidelines was performed. Four databases were searched for articles published from inception to June 2018: Medline; Embase; the Cumulative Index to Nursing and Allied Health Literature and; Scopus. The search strategy included MeSH and text words related to RRCT. Results: We identified 2369 articles of which 75 were selected for full-text screening. Of these, only 17 articles satisfied our inclusion criteria. All studies were published between 1996 and 2017 and all were investigator-initiated. Study designs were mainly multi-site comparative/effectiveness studies incorporating the use of disease registries (n = 8), procedure registries (n = 8) and a health services registry (n = 1). The low cost, reduced administrative burden and enhanced external validity of RRCTs make them an attractive research methodology which can be used to address questions of public health importance. We identified that that there are variable definitions of what constituted a RRCT and that issues related to ethical conduct and data integrity, completeness, timeliness, validation and endpoint adjudication need to be carefully addressed. Conclusion: RRCTs potentially have an important role to play in informing best clinical practice and health policy. There are a number of issues that need to be addressed to optimise the utility of this approach, including establishing universally accepted criteria for the definition of a RRCT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
The Randomized Registry Trial — The Next Disruptive Technology in Clinical Research?
Lauer, M. S., & D'Agostino, R. B. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1310102 · Cited by 595 · cited 1×
“Despite these benefits, there are several challenges in the design and implementation of RRCTs that need to be addressed, including: data quality, regulatory and ethical issues, adjudication of study outcomes, choice of methodology and study design, and operational challenges emanating from the type of clinical regist…”
BackgroundRegistry-based randomized clinical trials—a new clinical trial paradigm
James, S., Rao, S. V., & Granger, C. B. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.33 · Cited by 331
Exploring the ethical and regulatory issues in pragmatic clinical trials
Califf, R. M., & Sugarman, J. (2015) · Clinical Trials · doi:10.1177/1740774515598334 · Cited by 191
Re‐inventing the randomized controlled trial in medical oncology: The registry‐based trial
Foroughi, S., Wong, H., Gately, L., Lee, M., Simons, K., Tie, J., Burgess, A. W., & Gibbs, P. (2018) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12992 · Cited by 43
Self-citationA national strategy to develop pragmatic clinical trials infrastructure
Concannon, T. W., Guise, J., Dolor, R. J., Meissner, P., Tunis, S., Krishnan, J. A., Pace, W. D., Saltz, J., Hersh, W. R., Michener, L., et al. (2014) · Clinical and Translational Science · doi:10.1111/cts.12143 · Cited by 31
The Randomized Registry Trial: Two Birds, One Stone
Liu, J. B., D’Angelica, M. I., & Ko, C. Y. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002166 · Cited by 15 · cited 2×
“Data validity and data integrity of registries are critical elements in realising the full potential and scope of RRCTs [14].”
Background
Research works printed but not linked: 36
- Fitzpatrick T, Perrier L, Tricco AC, Straus SE, Juni P, Zwarenstein M, et al. Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data. BMJ Open. 2017;7(2):e013770. · DOI
- Li G, Sajobi TT, Menon BK, Korngut L, Lowerison M, James M, et al. Registry-based randomized controlled trials—what are the advantages, challenges, and areas for future research? J Clin Epidemiol. 2016;80:16–24. · DOI · Paper page
- Bergqvist D, Bjorck M, Sawe J, Troeng T. Randomized trials or population-based registries. Eur J Vasc Endovasc Surg. 2007;34(3):253–6. · DOI
- Barnish MS, Turner S. The value of pragmatic and observational studies in health care and public health. Pragmatic Observational Res. 2017;8:49–55. · DOI · Paper page
- Erlinge D, Omerovic E, Frobert O, Linder R, Danielewicz M, Hamid M, et al. Bivalirudin versus heparin monotherapy in myocardial infarction. N Engl J Med. 2017;377(12):1132–42. · DOI · Paper page
- Mathes T, Buehn S, Prengel P, Pieper D. Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials. J Clin Epidemiol. 2018;93:120–7. · DOI
- Mc Cord KA, Al-Shahi Salman R, Treweek S, Gardner H, Strech D, Whiteley W, et al. Routinely collected data for randomized trials: promises, barriers, and implications. Trials [Electronic Resource]. 2018;19(1):29.
- James S, Frobert O, Lagerqvist B. Cardiovascular registries: a novel platform for randomised clinical trials. Heart. 2012;98(18):1329–31. · DOI
- Jones WS, Roe MT, Antman EM, Pletcher MJ, Harrington RA, Rothman RL, et al. The changing landscape of randomized clinical trials in cardiovascular disease. J Am Coll Cardiol. 2016;68(17):1898–907. · DOI
- Gliklich RE, Dreyer NA, Leavy MB. Registries for evaluating patient outcomes: a user’s guide. 3rd ed. Rockville: Agency for Healthcare Research and Quality; 2014.
- Meinecke AK, Welsing P, Kafatos G, Burke D, Trelle S, Kubin M, et al. Series: pragmatic trials and real world evidence: Paper 8. Data collection and management. J Clin Epidemiol. 2017;91:13–22. · DOI
- Frobert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369(17):1587–97. · DOI · Paper page
- Rao SV, Hess CN, Barham B, Aberle LH, Anstrom KJ, Patel TB, et al. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv. 2014;7(8):857–67. · DOI · Paper page
- Maier B, Wagner K. Comparing routine administrative data with registry data for assessing quality of hospital care in patients with myocardial infarction using deterministic record linkage. BMC Health Serv Res. 2016;16(605). https://doi.org/10.1186/s12913-016-1840-5. · DOI
- The Joanna Briggs Institute. The Joanna Briggs Institute reviewers' manual 2015: Methodology for JBI scoping reviews. 2015.
- Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. · DOI · Paper page
- Jensen LO, Thayssen P, Maeng M, Ravkilde J, Krusell LR, Raungaard B, et al. Randomized Comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention. The SORT OUT VII Trial. Circ Cardiovasc Interv. 2016;9(7):e003610. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003610. · doi:10.1161/circinterventions.115.003610
- Lagerqvist B, Frobert O, Olivecrona GK, Gudnason T, Maeng M, Alstrom P, et al. Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med. 2014;371(12):1111–20. · DOI · Paper page
- Kristensen B, Ejlertsen B, Mouridsen HT, Andersen KW, Lauritzen JB. Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen. Breast Cancer Res Treat. 1996;39(3):321–6. · DOI
- Daley MF, Steiner JF, Brayden RM, Xu S, Morrison S, Kempe A. Immunization registry-based recall for a new vaccine. Ambul Pediatr. 2002;2(6):438–43. · DOI
- Dombkowski KJ, Harrington LB, Dong S, Clark SJ. Seasonal influenza vaccination reminders for children with high-risk conditions: a registry-based randomized trial. Am J Prev Med. 2012;42(1):71–5. · DOI
- Dombkowski KJ, Costello LE, Harrington LB, Dong S, Kolasa M, Clark SJ. Age-specific strategies for immunization reminders and recalls: a registry-based randomized trial. Am J Prev Med. 2014;47(1):1–8. · DOI
- Kempe A, Daley MF, Barrow J, Allred N, Hester N, Beaty BL, et al. Implementation of universal influenza immunization recommendations for healthy young children: results of a randomized, controlled trial with registry-based recall. Pediatrics. 2005;115(1):146–54. · DOI · Paper page
- LeBaron CW, Starnes DM, Rask KJ. The impact of reminder-recall interventions on low vaccination coverage in an inner-city population. Arch Pediatr Adolesc Med. 2004;158(3):255–61. · DOI · Paper page
- Irigoyen MM, Findley S, Wang D, Chen S, Chimkin F, Pena O, et al. Challenges and successes of immunization registry reminders at inner-city practices. Ambul Pediatr. 2006;6(2):100–4. · DOI
- Hall AE, Sanson-Fisher RW, Lynagh MC, Threlfall T, D’Este CA. Format and readability of an enhanced invitation letter did not affect participation rates in a cancer registry-based study: a randomized controlled trial. J Clin Epidemiol. 2013;66(1):85–94. · DOI
- Barbanti M, Gulino S, Capranzano P, Imme S, Sgroi C, Tamburino C, et al. Acute kidney injury with the RenalGuard system in patients undergoing transcatheter aortic valve replacement. The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc Interv. 2015;8(12):1595–604. · doi:10.1016/j.jcin.2015.07.012
- van der Veer SN, de Vos ML, van der Voort PH, Peek N, Abu-Hanna A, Westert GP, et al. Effect of a multifaceted performance feedback strategy on length of stay compared with benchmark reports alone: a cluster randomized trial in intensive care. Crit Care Med. 2013;41(8):1893–904. · DOI
- Alexander KP, Wang TY, Li S, Lytle BL, Slattery LE, Calhoun S, et al. Randomized trial of targeted performance feedback to facilitate quality improvement. Circ Cardiovasc Qual Outcomes. 2011;4(1):129–35. · DOI
- Hofmann R, James SK, Jernberg T, Lindahl B, Erlinge D, Witt N, et al. Oxygen therapy in suspected acute myocardial infarction. N Engl J Med. 2017;377(13):1240–9. · DOI · Paper page
- Ieva F, Gale CP, Sharples LD. Contemporary roles of registries in clinical cardiology: when do we need randomized trials? Expert Rev Cardiovasc Ther. 2014;12(12):1383–6. · DOI
- Ashrafi R, Hussain H, Brisk R, Boardman L, Weston C. Clinical disease registries in acute myocardial infarction. World J Cardiol. 2014;6(6):415–23. · DOI
- Kwakkenbos L, Juszczak E, Hemkens LG, Sampson M, Fröbert O, Relton C, et al. Protocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data. Res Integrity Peer Rev. 2018;3(1):9. · DOI
- Schmidt M, Maeng M, Jakobsen C-J, Madsen M, Thuesen L, Nielsen PH, et al. Existing data sources for clinical epidemiology: the Western Denmark Heart Registry. Clin Epidemiol. 2010;2:137. · DOI · Paper page
- Christiansen P, Ejlertsen B, Jensen M-B, Mouridsen H. Danish Breast Cancer Cooperative Group. Clin Epidemiol. 2016;8:445. · doi:10.2147/clep.s99457
- Dehmer GJ, Weaver D, Roe MT, Milford-Beland S, Fitzgerald S, Hermann A, et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol. 2012;60(20):2017–31. · DOI
Cited by
Harnessing Real-World Evidence to Advance Cancer Research
Tang, M., Pearson, S.-A., Simes, R. J., & Chua, B. H. (2023) · Current Oncology · doi:10.3390/curroncol30020143 · Cited by 88
Registry-based randomised controlled trials: conduct, advantages and challenges—a systematic review
Shiely, F., O Shea, N., Murphy, E., & Eustace, J. (2024) · Trials · doi:10.1186/s13063-024-08209-3 · Cited by 24
Dental Research in the Digital Age: The Registry-Based Clinical Trial.
Joda, T., Settecase, E., Heitz‐Mayfield, L., Derks, J., Jung, R. E., & Zitzmann, N. U. (2026) · Clinical oral implants research · doi:10.1111/clr.70061 · Cited by 2
Metadata
- Authors
- Karanatsios, B., Prang, K.-H., Verbunt, E., Yeung, J. M., Kelaher, M., & Gibbs, P.
- Venue
- Trials
- Published
- 2020-06-22
- Volume
- 21
- Issue
- 1
- Pages
- 552-552
- ISSN
- 1745-6215 (ISSN-L)
- OpenAlex
- W3036109214
- Cited by
- 92
- References
- 7
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- NA (NA)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Defining key design elements of registry-based randomised controlled trials: a scoping review. https://app.cochat.ai/papers/10.1186/s13063-020-04459-z
- The paper
- Karanatsios, B., Prang, K.-H., Verbunt, E., Yeung, J. M., Kelaher, M., & Gibbs, P. (2020). Defining key design elements of registry-based randomised controlled trials: a scoping review. Trials. https://doi.org/10.1186/s13063-020-04459-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.